Latest filing published 11 Dec 2020 for Khiron Life Sciences Corp., €6,281.
No signal scores available.
All filings by Deborah Rosati on record concern Khiron Life Sciences Corp. In total, 3 filings cover trades dated from 4 November 2019 to 10 December 2020.
No open-market sale appears; the market trades are 2 purchases worth €13k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2020 alone, the filings show 2 purchases and no sales.
The record was last updated on 11 December 2020 with an open-market purchase (€6,281) in Khiron Life Sciences Corp. The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations